{
  "abstract": "Comorbidities in idiopathic pulmonary fibrosis (IPF) have a relevant prognostic role as nearly 30–40% of patients die from causes that are not directly related to the disease itself.1 In this context, lung cancer represents a relevant topic as the risk of lung cancer in people with IPF has been reported to be markedly increased,2 being largely diagnosed during the clinical and radiological follow-up for fibrosis.",
  "authors": [
    {
      "affiliations": [
        "Biomedical Sciences and Public Health, Polytechnic University of Marche, Ancona, Italy",
        "University of Nottingham, Nottingham, UK"
      ],
      "name": "Francesca Gonnelli"
    },
    {
      "affiliations": [
        "Biomedical Sciences and Public Health, Polytechnic University of Marche, Ancona, Italy"
      ],
      "name": "Martina Bonifazi"
    }
  ],
  "title": "Lung cancer in idiopathic pulmonary fibrosis: do antifibrotics have a preventive effect?",
  "uid": "b5f87021-bcc2-5e57-9d98-7bec4444f3f0"
}